Hopewell Junction, NY, United States of America

Vadim Alexandrov

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Hopewell Junction, NY (US) (2017 - 2021)
  • Tarrytown, NY (US) (2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Vadim Alexandrov

Introduction

Vadim Alexandrov, an accomplished inventor based in Hopewell Junction, NY, has made significant contributions to the field of pharmaceutical research. With a portfolio of five patents, he has shown a dedicated commitment to developing innovative solutions for treating central nervous system (CNS) disorders.

Latest Patents

Vadim's latest patents include innovative compounds designed specifically for treating various neurological and psychiatric disorders. One of his notable inventions is a series of heterocyclyl isochromanyl compounds and their analogs, which have been disclosed as valuable resources for addressing CNS-related conditions. These compounds, together with their pharmaceutically acceptable salts, offer new methods for treatment, showcasing a comprehensive understanding of pharmaceutical compositions and their therapeutic applications.

Career Highlights

Throughout his career, Vadim has worked with several notable organizations, including Sunovion Pharmaceuticals Inc. and Pgi Drug Discovery LLC. His experience within these companies has allowed him to refine his expertise and contribute to significant advancements in drug discovery and development.

Collaborations

Vadim has collaborated with several professionals in his field, including Taleen G. Hanania and Noel Aaron Powell. These partnerships reflect the collaborative nature of innovation in pharmaceutical research, as inventors often rely on the insights and expertise of their coworkers to advance their projects.

Conclusion

Vadim Alexandrov's work exemplifies the innovative spirit within the pharmaceutical industry. His developed compounds and ongoing research efforts continue to pave the way for new treatments for CNS disorders. As he moves forward in his career, his dedication to invention and collaboration will undoubtedly lead to further breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…